Gamified walking and exercise may lower heart disease risk

NCT ID NCT07360561

ENROLLING_BY_INVITATION Disease control Sponsor: Uludag University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 12-week program combining daily walking, high-intensity circuit training, and a gamified mobile app can improve cardiovascular risk factors like cholesterol, blood pressure, and body fat. Researchers will enroll 105 university students and staff, dividing them into five groups to compare different combinations of walking, exercise, and gamification. The goal is to see if making physical activity fun and engaging can lead to lasting heart health benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Walking program, high-intensity circuit training, and gamified mobile application
What this could lead to: If successful, this approach could offer a fun, low-cost way to reduce heart disease risk through increased physical activity.
What could go wrong: This is a small, early-stage study (105 participants) with no blinding or placebo, so results may not apply broadly. The intervention is short (12 weeks), and long-term adherence is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLLEGE STUDENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLLEGE STUDENT EXERCISE GAMIFICATION PHYSICAL ACTIVITY UNIVERSITY STUDENT

Contacts and locations

Locations

Uludağ University, Faculty of Spor Science Lab

Bursa, NİLÜFER, 16120, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.